Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Cardinal Health | 5.41% | $2.06M | $52.77B | 76.88% | 66 Neutral | |
| Eli Lilly & Co | 5.19% | $1.97M | $959.76B | 16.44% | 72 Outperform | |
| Waste Management | 4.98% | $1.89M | $94.65B | 3.10% | 76 Outperform | |
| Johnson & Johnson | 4.93% | $1.88M | $580.30B | 53.17% | 78 Outperform | |
| McKesson | 4.88% | $1.85M | $116.75B | 58.21% | 62 Neutral | |
| Rentokil Initial | 4.86% | $1.85M | $16.16B | 22.69% | 66 Neutral | |
| Chubb | 4.45% | $1.69M | $129.51B | 22.91% | 80 Outperform | |
| Coca-Cola | 4.40% | $1.67M | $338.11B | 13.09% | 75 Outperform | |
| Casey's General | 4.27% | $1.62M | $24.05B | 46.60% | 68 Neutral | |
| Northrop Grumman | 4.22% | $1.60M | $96.34B | 49.17% | 76 Outperform |